Literature DB >> 12901776

Relationship between positive and negative symptoms and neuropsychological scores in frontotemporal dementia and Alzheimer's disease.

Kyle Brauer Boone1, Bruce L Miller, Randolph Swartz, Po Lu, Alison Lee.   

Abstract

Patients with dementia, particularly those with frontotemporal dementia (FTD), are reported to display marked negative symptoms, including apathy, lack of initiative, and flattened affect, similar to those observed in schizophrenic patients. However, negative symptoms have yet to be formally quantified in an FTD population. Twenty-seven patients with FTD (11 primarily right-sided, 8 primarily left-sided, and 4 symmetric) and 7 patients with Alzheimer's disease were rated on the Scale for the Assessment of Negative Symptoms, the Positive and Negative Syndrome Scale, and the Emotional Blunting scale. The FTD patients registered significantly more negative symptoms than the Alzheimer's patients, averaging a threefold increase; groups did not significantly differ in positive symptoms. Negative symptom scale scores were negatively correlated with nonverbal executive skills (23-44% shared variance), verbal executive skills (up to 25% shared variance) and verbal memory (up to 20% shared variance), but were unrelated to measures of attention, verbal and nonverbal information processing, nonverbal memory, language, and constructional skill. In contrast, positive symptoms were positively correlated with constructional skill (19% shared variance) and attentional scores (15% shared variance). These findings add to the existing literature relating negative symptoms to anterior cerebral hypofunction, and suggest that positive symptoms, at least in this population, may be tied to increased posterior activation.

Entities:  

Mesh:

Year:  2003        PMID: 12901776     DOI: 10.1017/S135561770395003X

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  9 in total

1.  Neuroanatomical correlates of emotional blunting in behavioral variant frontotemporal dementia and early-onset Alzheimer's disease.

Authors:  Grace J Lee; Po H Lu; Michelle J Mather; Jill Shapira; Elvira Jimenez; Alex D Leow; Paul M Thompson; Mario F Mendez
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  Social Withdrawal Among Individuals Receiving Psychiatric Care: Derivation of a Scale Using Routine Clinical Assessment Data to Support Screening and Outcome Measurement.

Authors:  Sebastian Rios; Christopher M Perlman
Journal:  J Behav Health Serv Res       Date:  2018-10       Impact factor: 1.505

3.  Apathy in frontotemporal dementia: behavioral and neuroimaging correlates.

Authors:  Paul J Eslinger; Peachie Moore; Shweta Antani; Chivon Anderson; Murray Grossman
Journal:  Behav Neurol       Date:  2012       Impact factor: 3.342

4.  Evaluation of emotional blunting in behavioral variant frontotemporal dementia compared to Alzheimer's disease.

Authors:  Aditi Joshi; Joseph P Barsuglia; Michelle J Mather; Elvira E Jimenez; Jill Shapira; Mario F Mendez
Journal:  Dement Geriatr Cogn Disord       Date:  2014-03-01       Impact factor: 2.959

Review 5.  Neuropsychological deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic review.

Authors:  A D Hutchinson; J L Mathias
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-19       Impact factor: 10.154

6.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.

Authors:  Katya Rascovsky; John R Hodges; David Knopman; Mario F Mendez; Joel H Kramer; John Neuhaus; John C van Swieten; Harro Seelaar; Elise G P Dopper; Chiadi U Onyike; Argye E Hillis; Keith A Josephs; Bradley F Boeve; Andrew Kertesz; William W Seeley; Katherine P Rankin; Julene K Johnson; Maria-Luisa Gorno-Tempini; Howard Rosen; Caroline E Prioleau-Latham; Albert Lee; Christopher M Kipps; Patricia Lillo; Olivier Piguet; Jonathan D Rohrer; Martin N Rossor; Jason D Warren; Nick C Fox; Douglas Galasko; David P Salmon; Sandra E Black; Marsel Mesulam; Sandra Weintraub; Brad C Dickerson; Janine Diehl-Schmid; Florence Pasquier; Vincent Deramecourt; Florence Lebert; Yolande Pijnenburg; Tiffany W Chow; Facundo Manes; Jordan Grafman; Stefano F Cappa; Morris Freedman; Murray Grossman; Bruce L Miller
Journal:  Brain       Date:  2011-08-02       Impact factor: 13.501

7.  An approach to and the rationale for the pharmacological management of behavioral and psychological symptoms of dementia.

Authors:  Manjari Tripathi; Deepti Vibha
Journal:  Ann Indian Acad Neurol       Date:  2010-12       Impact factor: 1.383

8.  Quantitative electroencephalographic and neuropsychological investigation of an alternative measure of frontal lobe executive functions: the Figure Trail Making Test.

Authors:  Paul S Foster; Valeria Drago; Brad J Ferguson; Patti Kelly Harrison; David W Harrison
Journal:  Brain Inform       Date:  2015-11-26

Review 9.  Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.

Authors:  Christopher H van Dyck; Amy F T Arnsten; Prasad R Padala; Olga Brawman-Mintzer; Alan J Lerner; Anton P Porsteinsson; Roberta W Scherer; Allan I Levey; Nathan Herrmann; Nimra Jamil; Jacobo E Mintzer; Krista L Lanctôt; Paul B Rosenberg
Journal:  Am J Geriatr Psychiatry       Date:  2020-05-05       Impact factor: 4.105

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.